Back to results
US 2022/0024845 A1Published application
Compounds and methods for delivery of prostacyclin analogs
AssigneeUnited Therapeutics Corporation
InventorKen PHARES
Life of this patent
Estimating the term…
Abstract
This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing
Claims12
A method of treating pulmonary hypertension, comprising administering to a patient in need thereof a pharmaceutical composition comprising a) an effective amount of treprostinil or a pharmaceutically acceptable salt or ester thereof and b) polysorbate 80.
Dependencies are inferred from the claim text.